Recordati Rare Diseases North America
Chad Morris is currently the National Business Director in the Metabolic Division at Recordati Rare Diseases Inc. Chad has a strong background in sales and account management, with previous roles at InSight Telepsychiatry, LLC., Lundbeck, Abbott Laboratories, Janssen, and NuVox. Chad graduated from Missouri State University with a Bachelor of Science in Media Production.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.